{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:40:41Z","timestamp":1794624041929,"version":"4.9.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research Foundation\u2014Flanders (Belgium)","award":["1.8.029.20N"],"award-info":[{"award-number":["1.8.029.20N"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Nailfold videocapillaroscopy (NVC) plays a well-established role in differentiating primary from secondary RP due to SSc. However, the association of NVC with novel severe organ involvement\/progression in SSc has never been evaluated in a multicentre, multinational study, which we now perform for the first time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Follow-up data from 334 SSc patients [265 women; 18 limited SSc (lSSc)\/203 lcSSc\/113 dcSSc] registered between November 2008 and January 2016 by seven tertiary centres in the EUSTAR-database, were analysed. Novel severe organ involvement\/progression was defined as new\/progressive involvement of the peripheral vasculature, lungs, heart, skin, gastrointestinal tract, kidneys, musculoskeletal system, or death, at the 12- or 24-month follow-up. NVC images at enrolment were quantitatively and qualitatively evaluated according to the standardized definitions of the EULAR Study Group on Microcirculation in Rheumatic Diseases. Uni- and multivariable logistic regression modelling (ULR, MLR) was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 334 included SSc patients, 257 (76.9%) developed novel overall severe organ involvement\/progression. Following MLR, normal capillary density was associated with less-frequent novel overall severe organ involvement\/progression [odds ratio (OR)\u2009=\u20090.77, P\u2009&amp;lt;\u20090.001] and novel peripheral vascular involvement (OR\u2009=\u20090.79, P\u2009=\u20090.043); microhaemorrhages were associated with less novel pulmonary hypertension (OR\u2009=\u20090.47, P\u2009=\u20090.029); and a \u2018severe\u2019 (active\/late) NVC pattern was associated with novel overall severe organ involvement\/progression (OR\u2009=\u20092.14, P\u2009=\u20090.002) and skin progression (OR\u2009=\u20091.70, P\u2009=\u20090.049).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results suggest that NVC may be a promising biomarker in SSc, certainly warranting further investigation. Despite the participation of tertiary centres, which follow their patients in a standardized way, we were underpowered to detect associations with infrequent severe organ involvement\/progression.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac079","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T13:39:38Z","timestamp":1644932378000},"page":"4384-4396","source":"Crossref","is-referenced-by-count":52,"title":["Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement\/progression?"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1989-7060","authenticated-orcid":false,"given":"Amber","family":"Vanhaecke","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ghent University"},{"name":"Department of Rheumatology, Ghent University Hospital , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino Polyclinic Hospital , Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich , Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Riccieri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties, Sapienza University of Rome , Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick\u00a0","family":"Allanore","sequence":"additional","affiliation":[{"name":"Service de Rheumatology, Universit\u00e9 de Paris, H\u00f4pital\u00a0Cochin, AP-HP CUP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-8938","authenticated-orcid":false,"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University College London, Royal Free Hospital , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[{"name":"Institute for Translational Research in Inflammation (INFINITE), Universit\u00e9 de Lille"},{"name":"INSERM"},{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes Syst\u00e9miques Rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6727-1273","authenticated-orcid":false,"given":"Francesca","family":"Ingegnoli","sequence":"additional","affiliation":[{"name":"Division of Clinical Rheumatology, ASST Pini-CTO"},{"name":"Department of Clinical Sciences and Community Health, Universit\u00e0 degli Studi di Milano , Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen\u00a0","family":"Deschepper","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Department of Public Health and Primary Care, Ghent University , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2463-218X","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"additional","affiliation":[{"name":"Service de Rheumatology, Universit\u00e9 de Paris, H\u00f4pital\u00a0Cochin, AP-HP CUP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Jordan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich , Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[{"name":"Institute for Translational Research in Inflammation (INFINITE), Universit\u00e9 de Lille"},{"name":"INSERM"},{"name":"Service de M\u00e9decine Interne et Immunologie Clinique, Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes Syst\u00e9miques Rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4125-7163","authenticated-orcid":false,"given":"Karin","family":"Melsens","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ghent University"},{"name":"Department of Rheumatology, Ghent University Hospital , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pizzorni","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino Polyclinic Hospital , Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3674-4880","authenticated-orcid":false,"given":"Alberto","family":"Sulli","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino Polyclinic Hospital , Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Vasile","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Medical Specialties, Sapienza University of Rome , Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-7926","authenticated-orcid":false,"given":"Ariane L","family":"Herrick","sequence":"additional","affiliation":[{"name":"Division of Musculoskeletal and Dermatological Sciences, University of Manchester, Salford Royal NHS Foundation Trust"},{"name":"NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-7945","authenticated-orcid":false,"given":"Vanessa\u00a0","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ghent University"},{"name":"Department of Rheumatology, Ghent University Hospital , Ghent, Belgium"},{"name":"Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre (IRC) , Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"2022110207585184600_keac079-B1","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21(Suppl 29","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2022110207585184600_keac079-B2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B3","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B4","doi-asserted-by":"crossref","first-page":"1902026","DOI":"10.1183\/13993003.02026-2019","article-title":"Predictors of progression in systemic sclerosis patients with interstitial lung disease","volume":"55","author":"Distler","year":"2020","journal-title":"Eur Respir J"},{"key":"2022110207585184600_keac079-B5","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2022110207585184600_keac079-B6","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3899\/jrheum.130528","article-title":"Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis","volume":"40","author":"Smith","year":"2013","journal-title":"J Rheumatol"},{"key":"2022110207585184600_keac079-B7","first-page":"e000782","article-title":"Systemic sclerosis: state of the art on clinical practice guidelines","volume":"4(Suppl 1","author":"Smith","year":"2018","journal-title":"RMD Open"},{"key":"2022110207585184600_keac079-B8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/qjmed\/hcp174","article-title":"Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study","volume":"103","author":"Nihtyanova","year":"2010","journal-title":"QJM"},{"key":"2022110207585184600_keac079-B10","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","article-title":"Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study","volume":"71","author":"Smith","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3899\/jrheum.190296","article-title":"Nailfold videocapillaroscopy in systemic sclerosis\u2013related pulmonary arterial hypertension: a systematic literature review","volume":"47","author":"Smith","year":"2020","journal-title":"J Rheumatol"},{"key":"2022110207585184600_keac079-B12","doi-asserted-by":"crossref","first-page":"102619","DOI":"10.1016\/j.autrev.2020.102619","article-title":"May capillaroscopy be a candidate tool in future algorithms for SSC-ILD: are we looking for the holy grail? A systematic review","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2022110207585184600_keac079-B13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.semarthrit.2018.02.005","article-title":"Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review","volume":"48","author":"Paxton","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2022110207585184600_keac079-B14","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2018s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2022110207585184600_keac079-B15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41584-021-00685-0","article-title":"Detection of microvascular changes in systemic sclerosis and other rheumatic diseases","volume":"17","author":"Cutolo","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2022110207585184600_keac079-B16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/art.33463","article-title":"Timing of transition between capillaroscopic patterns in systemic sclerosis","volume":"64","author":"Sulli","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022110207585184600_keac079-B17","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud\u2018s phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2022110207585184600_keac079-B18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","article-title":"Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis","volume":"47","author":"Avouac","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2022110207585184600_keac079-B19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/rheumatology\/keaa226","article-title":"Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study","volume":"59","author":"Sulli","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2022110207585184600_keac079-B20","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/art.39718","article-title":"Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study","volume":"68","author":"Cutolo","year":"2016","journal-title":"Arthritis Rheum"},{"key":"2022110207585184600_keac079-B21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3899\/jrheum.181408","article-title":"Might nailfold capillaroscopy be a \u201cProxy\u201d for lung involvement in connective tissue diseases?","volume":"46","author":"Smith","year":"2019","journal-title":"J Rheumatol"},{"key":"2022110207585184600_keac079-B22","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/ard.2009.115568","article-title":"Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study","volume":"69","author":"Smith","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B23","first-page":"155","article-title":"Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J Rheumatol"},{"key":"2022110207585184600_keac079-B24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/rheumatology\/kex460","article-title":"Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases","volume":"57","author":"Cutolo","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2022110207585184600_keac079-B25","doi-asserted-by":"crossref","first-page":"102394","DOI":"10.1016\/j.autrev.2019.102394","article-title":"Fast track algorithm: how to differentiate a \u201cscleroderma pattern\u201d from a \u201cnon-scleroderma pattern\u201c","volume":"18","author":"Smith","year":"2019","journal-title":"Autoimmun Rev"},{"key":"2022110207585184600_keac079-B26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kev441","article-title":"An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases","volume":"55","author":"Smith","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2022110207585184600_keac079-B27","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B28","first-page":"63","article-title":"Correlation between capillaroscopic classifications and severity in systemic sclerosis: results from SCLEROCAP study at inclusion","volume":"37(Suppl 119","author":"Boulon","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2022110207585184600_keac079-B29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022110207585184600_keac079-B30","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J\u00a0Rheumatol"},{"key":"2022110207585184600_keac079-B31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","article-title":"Progressive interstitial lung disease in patients with systemic sclerosis\u2013associated interstitial lung disease in the EUSTAR database","volume":"80","author":"Hoffmann-Vold","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BOR.0000000000000592","article-title":"Management of systemic sclerosis\u2013associated interstitial lung disease","volume":"31","author":"Roofeh","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2022110207585184600_keac079-B34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"2022110207585184600_keac079-B35","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3899\/jrheum.141182","article-title":"Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) \u2013 report from OMERACT CTD-ILD Working Group","volume":"42","author":"Khanna","year":"2015","journal-title":"J Rheumatol"},{"key":"2022110207585184600_keac079-B36","first-page":"267","volume-title":"2nd International Symposium on Information Theory, Tsahkadsor, Armenia, USSR, 1971","author":"Akaike","year":"1973"},{"key":"2022110207585184600_keac079-B37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"2022110207585184600_keac079-B38","first-page":"411","article-title":"What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models","volume":"66","author":"Babyak","year":"2004","journal-title":"Psychosom Med"},{"key":"2022110207585184600_keac079-B39","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13075-019-2032-6","article-title":"NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity","volume":"21","author":"Pignataro","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2022110207585184600_keac079-B40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13075-020-02342-5","article-title":"High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis","volume":"22","author":"Del Papa","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2022110207585184600_keac079-B41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13075-017-1354-5","article-title":"The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score","volume":"19","author":"Andracco","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2022110207585184600_keac079-B42","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022110207585184600_keac079-B43","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.22721","article-title":"Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model","volume":"56","author":"Shand","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2022110207585184600_keac079-B44","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2022110207585184600_keac079-B45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/annrheumdis-2018-213455","article-title":"Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2022110207585184600_keac079-B46","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.semarthrit.2021.07.018","article-title":"Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in Flanders: a retrospective cohort study","volume":"51","author":"Vandecasteele","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2022110207585184600_keac079-B47","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheum"},{"key":"2022110207585184600_keac079-B48","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2022110207585184600_keac079-B49","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet (London)"},{"key":"2022110207585184600_keac079-B50","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-017-3936-7","article-title":"First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study","volume":"37","author":"Rubio-Rivas","year":"2018","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac079\/43114385\/keac079.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/11\/4384\/46747682\/keac079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/11\/4384\/46747682\/keac079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T08:00:24Z","timestamp":1667376024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/11\/4384\/6530300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,2,17]]},"published-print":{"date-parts":[[2022,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac079","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,2,17]]}}}